Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New article discusses EIS as a potential clinical measure of skin barrier integrity

STOCKHOLM, SWEDEN, — October 27, 2022 – SciBase Holding AB (“SciBase”) [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today that a recently published article in the journal “Molecular Psychiatry”, a part of Nature, named “Ectodermal origins of the skin-brain axis: a novel model for the developing brain, inflammation, and neurodevelopmental conditions”  discusses that EIS may represent an alternate clinical measure of skin barrier integrity that may function as a surrogate for neurodevelopmental divergence.The article describes

Sobi publishes Q3 2022 report

Swedish Orphan Biovitrum AB (publ)  (Sobi®) today announced its report for the third quarter of 2022   July – September 2022 · Total revenue SEK 3,999 M (3,761), +6 per cent, -6 per cent at constant exchange rates (CER)1 · Haematology revenue SEK 2,619 M (2,291), +3 per cent at CER of which Elocta® SEK 1,041 M (1,035), -5 per cent at CER; Alprolix® SEK 464 M (430), +2 per cent at CER; Doptelet® SEK 543 M (400), +12 per cent at CER and Aspaveli®/Empaveli™ SEK 49 M (-) · Immunology revenue SEK 1,070 M (1,144), -22 per cent at CER of which Kineret® SEK

Stille AB: Interim Report Q3 2022

Stille AB (publ) publishes the interim report for the third quarter of 2022. ”The first three quarters of this year has displayed significant growth coupled with solid profitability. The third quarter continued the positive trend achieved during previous quarters this year”, says Hanna Ernestam Wilkman, Stille’s CEO.Revenues increased by 17 percent to 59.6 MSEK (51.1). Operating profit increased by 32 percent to 7.2 MSEK (5.5). Positive currency effects of 2.7 MSEK affected the result after financial items. Revenues for Surgical Instruments increased by six percent to 30.1 MSEK (28.4).

Redundancy negotiations at Rottneros Mill finalized

The decision to shut down the groundwood pulp line for printing paper at Rottneros Mill, led to a notice to reduce the number of employees by 40 people. The negotiations are finalized and 35 people will be made redundant. Of these, 17 employees have agreed to a pension solution and 18 have been dismissed.We have had a very good climate in the negotiations and have together found solutions, says the group's COO Peter Sävelin.  A total of 35 people will be made redundant when the new organization will be in effect from the turn of the year.. The parties also agreed that those who turn 60

Interim report Q3, 2022: Actions done and synergies ahead

Third quarter · Sales of SEK 798 (406) million, corresponding to an increase of 97% in SEK, whereof acquired growth 75% and currency effect 20%. Sales pro forma, adjusted for business related to Covid-19 tests, increased by 5% in local currencies. · Consumables increased sales by 18% in SEK, Technologies decreased by 5% in SEK, and Genetic Services contributed sales of SEK 348 million. · Including the acquisition, we have strong growth in all market regions. Americas 222%, EMEA 33%, Japan Pacific 88% and Asia 33% in local currencies. · Organic growth in local currency, pro

Neste's Interim Report for January–September 2022

Neste Corporation, Interim Report, 27 October 2022 at 9 a.m. (EET) Strong performance continued in exceptional markets Third quarter in brief:  · Comparable EBITDA totaled EUR 979 million (EUR 524 million) · EBITDA totaled EUR 456 million (EUR 735 million) · Renewable Products' comparable sales margin was USD 756/ton (USD 679/ton) · Oil Products' total refining margin was USD 28.0/bbl (USD 9.4/bbl) · Cash flow before financing activities was EUR -18 million (EUR 171 million) January-September in brief:  · Comparable EBITDA totaled EUR 2,643 million (EUR 1,329

Rottneros interim report January-September 2022

Record turnover and strong earningsNET TURNOVER increased by 41 percent to 806 (570) MSEK, which is a new quarterly record.   THE LIST PRICE of NBSK pulp in Europe was 11 percent higher in USD and 35 percent higher in SEK compared with the third quarter of 2021. At the end of the quarter, the list price was 1 497 USD.   PRODUCED VOLUME amounted to 96,2 (92,2) thousand tons. Production at Rottneros Mill was affected by the annual maintenance shutdown, as well as by the high electricity prices.  SOLD VOLUME amounted to 95,9 (92,5) thousand tons. Demand for Rottneros’ products

Terveystalo Group Interim Report January-September 2022

Profitability significantly weakened due to changes in the sales mix and increased costs, 50-million-euro annualized profit improvement program underway Terveystalo Plc, Interim Report January-September 2022, 27 October 2022 at 09:00 EEST   This release is a summary of Terveystalo's Interim Report January-September 2022. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/   July-September 2022 in brief •          Revenue increased by 1.2% year-on-year

Nordic Mining: Successful placement of USD 100 million senior secured bond

Nordic Mining ASA ("Nordic Mining") is pleased to announce that its wholly owned subsidiary Nordic Rutile AS (the "Issuer") has successfully issued USD 100 million in a new 5-year senior secured bond (the “Bond”). The Bond has fixed coupon of 12.5% per annum and an issue price of 90%. The issue was well subscribed by domestic and international quality investors such as pension funds, long-only credit funds, hedge funds and family offices. The settlement of the Bond is expected be on or around the 9 November 2022. The Issuer will make an application for the bonds to be listed on Nordic ABM.

Interim report January-September 2022

SLOWDOWN IN THE MARKET July-September 2022 · Order bookings amounted to SEK 2,684 million (1,195) · Income amounted to SEK 2,055 million (1,968) · The operating loss amounted to SEK 39 million (profit 25) · Cash flow from operating activities amounted to an outflow of SEK 261 million (inflow 207) · Cash flow for the period amounted to an outflow of SEK 133 million (inflow 268) · The loss for the period amounted to SEK 92 million (profit 37) · The equity/assets ratio was 37.6 percent (36.7) · In August, Serneke signed a contracting agreement for the

Polygiene Group AB (publ.) Interim Report July 1 – September 30, 2022

Reduced purchasing power and increased inventory turns distributors cautiousThe quarter in brief (July - September 2022) · Net sales amounted to MSEK 41.0 (52.3), a decrease by 21.7 % mainly due to reduced sales to the distributor level · The gross margin increased to 65.6 (64.3) % · The operating profit before depreciations EBITDA amounted to MSEK 5.1 (15.7), corresponding to an EBITDA margin of 12.5 (30.0) % · The operating profit after depreciations and before tax EBIT amounted to MSEK 7.0 (15.7), corresponding to an EBIT margin of 17.2 (30.0) % · The cash flow amounted

YIT’s Interim Report January-September 2022

YIT Corporation Stock exchange release 27 October 2022 at 9:00 a.m.Improved performance in a challenging business environment Third quarter 2022 highlights: · Adjusted operating profit increased to EUR 21 million (11). · Adjusted operating profit margin improved to 3.7% (2.0), reflecting a stable underlying performance across the segments. · Determined strategy execution continued successfully, while increased construction material costs had a negative impact on margins. · Result for the period was EUR 7 million (-3). · Operating cash flow after investments amounted to

Nightingale Health Plc: Adoption of International Financial Reporting Standards (IFRS) and unaudited financial information for the comparative period

Nightingale Health PlcCompany release 27 October 2022 at 9:00 a.m. (EEST) Nightingale Health Plc ("Nightingale Health" or the "Company") will publish its first consolidated financial statements prepared in accordance with IFRS for the financial year ended 30 June 2022. Nightingale Health has prepared the following unaudited IFRS financial information for the comparison periods to provide its investors with comparative information on Nightingale Health's consolidated statement of income, statement of financial position and key financials. Comparative information is provided for the

Einride Completes Historic Autonomous Vehicle Pilot on US Public Road With GE Appliances

The pilot marks the first time a fully electric autonomous heavy duty vehicle without a driver on board ran an operational pilot on U.S. public road October, 27, 2022 – Freight mobility technology company Einride  successfully completed a public road pilot of Einride’s autonomous, electric vehicle, in Selmer, Tennessee. After receiving the first U.S. approval for operations of this new type of vehicle from the National Highway Traffic Safety Administration (NHTSA) earlier this year, Einride completed this industry first by operating a fully autonomous, electric

Interim report for Duni AB (publ) January 1 - September 30, 2022

Sales increase, in a quarter without restrictionsJuly 1 – September 30 · Net sales amounted to SEK 1,834 m (1,453), corresponding to a 26.2% increase in sales. Adjusted for exchange rate movements, net sales increased by 19.2%. · Operating income was SEK 154 m (151), a historically strong result. · Inflation and high electricity prices continue to challenge, further price increases announced during the quarter. January 1 – September 30 · Net sales amounted to SEK 5,002 m (3,509), corresponding to a 42.5% increase in sales. Adjusted for exchange rate movements, net sales

Interim Report 1 January – 30 September 2022

Growth in a changing market AddLife´s interim report for Q3 2022 is now available online at the company website. The interim report can be downloaded in pdf version. Visit reports-en.add.life/interim-report-q3-2022  1 JULY – 30 SEPTEMBER 2022 (3 MONTHS) · Net sales increased by 14 percent to SEK 2,100m (1,850), of which acquired growth amounted to 16 percent. The COVID-19 related net sales decreased by 50 percent. The organic growth, excluding net sales related to COVID-19, was 2 percent. · EBITA increased by 1 percent

Interim Report January – September 2022

The market situation is still uncertain and difficult to assess with high inflation and rising financing costs. Buyers of forward funding projects are still waiting, and we did not have any project sales during the quarter. We are now seeing a sharp slowdown in new housing construction in Sweden. We have chosen to postpone several future projects that are not yet being constructed and we have reviewed our fixed costs. The results were weighed down by negative valuation effects, write-downs of projects and one-off effects. Thanks to our excellent building rights portfolio, and all our skilled

The Baltic Sea Festival is looking for musical collaborations with young scientists

Baltic Sea Festival Science Lab is a new Baltic Sea Festival event at the Swedish Radio concert hall Berwaldhallen jointly produced with Stockholm University and Voksenåsen Music Academies. Through this project nine young scientists from the Baltic Sea Region will be paired with nine young composers. Together, they will turn scientific research into music that will be performed by the Swedish Radio Symphony Orchestra during the Baltic Sea Festival 2023. Now open for applications. Baltic Sea Festival Science Lab brings together composers, scientists and musicians during the 2023

Kyoto introduces the Heatcube 2.0 cost-leading energy storage solution

Oslo, Norway 27 October 2022 – Kyoto Group today launched the second generation of the Heatcube thermal energy storage solution, offering up to five times higher energy density, lower cost and construction optimization.“Today, we introduce the most advanced and innovative system for storing and generating industrial heat based on thermal energy storage. It substantially lowers the cost of energy for industrial heat, which represents more than half of industrial energy consumption and is almost exclusively produced from fossil fuels,” says Bjarke Buchbjerg, CTO of Kyoto Group. “In short,

NextCell publishes its Year-End Report 2021/2022

NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Year-End Report for the period September 1, 2021 – August 31, 2022 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.Fourth quarter (2022-06-01 until 2022-08-31) ● Operating income amounted to 1 405 (1 381) TSEK. ● Operating result amounted to -8 563 (-4 457) TSEK. ● Earnings per share* amounted to

Cloetta AB interim report Q3: July – September 2022

Cloetta is reporting the seventh consecutive quarter of growth in Branded packaged products and continued profitable growth in Pick & mix. Further price increases were implemented during the quarter to compensate for the continuing cost inflation, whilst protecting volumes.· Net sales for the quarter increased by 14.8 per cent to SEK 1,798m (1,566) including a positive impact from foreign exchange rates of 3.3 per cent. · Sales of Branded packaged products increased organically by 10.2 per cent during the quarter. · Sales of Pick & mix increased organically by 15.7 per cent during the

Kindred Group plc – Interim report: January – September 2022 (unaudited)

Strategic value drivers in place and Netherlands off to a flying startThird quarter 2022 · Total revenue (B2C and B2B) was GBP 277.8 (298.4) million · Gross winnings revenue (B2C) decreased by 9 per cent to GBP 271.9 (298.4) million. Excluding the Netherlands, Gross winnings revenue increased by 8 per cent · Underlying EBITDA decreased by 52 per cent to GBP 40.3 (84.8) million · Profit before tax amounted to GBP 60.3 (71.8) million, impacted positively by the reassessment of the fair value of the Relax Gaming contingent consideration of GBP 39.6 million · Profit after tax

Teleste: Interim report Q3 2022 will be published on 3 November, 2022 – Invitation to press briefing

Teleste CorporationPress releaseOctober 27, 2022, at 8:30 a.m. EEST TELESTE: INTERIM REPORT Q3 2022 WILL BE PUBLISHED ON 3 NOVEMBER - INVITATION TO PRESS BRIEFING Teleste will publish its interim report 1 January – 30 September 2022 as a stock exchange release on 3 November approx. at 08:30 a.m. EET. A briefing for analysts, media, financial institutions and professional investors will be held virtually in Teams the same day at 09:30 a.m. EET hosted by CEO Esa Harju and CFO Juha Hyytiäinen. PRESS BRIEFING (held in Finnish): Date: Thursday, 3 November, 2022Time: 09:30-10:

Glaston’s interim report January–September 2022: Record high order intake at EUR 86.2 million in Q3

GLASTON CORPORATION              INTERIM  REPORT            27.10.2022 AT 8.30This release is a summary of Glaston Corporation's January-September 2022 interim report. The complete report is attached to this release as a pdf-file. The release is also available on the company's website at the address www.glaston.net.  JULY–SEPTEMBER 2022 IN BRIEF · Orders received totaled EUR 86.2 (45.4) million · Net sales totaled EUR 47.9 (46.4) million · Comparable EBITA was EUR 2.5 (3.2) million, i.e. 5.1 (6.9)% of net sales · The operating result (EBIT) was EUR 1.2 (2.3) million ·

There are no items matching the current filter
There are no more items matching the current filter
Back to top